EMD.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Healthcare Information Services

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2029	$32M	—	$0.00	$0.00–$0.00	—	0
2030	$6M	-81.1%	$0.00	$0.00–$0.00	—	0
2031	$4M	-29.5%	$-0.01	$-0.01–$-0.01	—	1
2032	$10M	+125.6%	$-0.01	$-0.01–$-0.01	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
EMD.AXEmyria Limited	$0.05	+10.64%	$30M	—
ADO.AXAnteoTech Limited	$0.02	+0.00%	$62M	—
AGN.AXArgenica Therapeutics Ltd	$0.17	+2.94%	$22M	—
BDX.AXBCAL Diagnostics Limited	$0.07	+0.00%	$26M	—
DOC.AXDoctor Care Anywhere Group PLC	$0.12	+0.00%	$44M	—
EYE.AXNova Eye Medical Limited	$0.13	-3.70%	$37M

Source: Financial Modeling Prep · peers by sector/industry

Emyria Limited

Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.

emyria.com

Employees: 6
IPO / List date: Feb 11, 2020
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds EMD.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in EMD.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded EMD.AX yet.